These findings reveal a novel AMPK phosphorylation‐dependent mechanism by which PAK4 regulates mitochondrial function and muscle mass, offering new therapeutic avenues for combating muscle atrophy in chronic disease and aging. The gene discussed is PRKAA1; the disease is Atrophy.